Etkin Amit 4
4 · Alto Neuroscience, Inc. · Filed May 15, 2026
Research Summary
AI-generated summary of this filing
Alto Neuroscience (ANRO) CEO Amit Etkin Gifts 400,000 Shares
What Happened Amit Etkin, President, CEO and a director of Alto Neuroscience (ANRO), transferred (gifted) 400,000 shares on 2026-05-14. The transaction is reported as a Gift (code G) at $0.00 per share, resulting in a reported transaction value of $0. The filing indicates this was an estate-planning transfer to an irrevocable trust for the benefit of his spouse and children.
Key Details
- Transaction date: 2026-05-14; Filing date: 2026-05-15 (timely filing).
- Transaction type/code: Gift (G).
- Shares transferred: 400,000; Price reported: $0.00; Reported transaction value: $0.
- Shares owned following the transaction: Not specified in the Form 4 filing.
- Footnote: The shares were transferred to the "Bard on Haven Trust," an irrevocable trust. The trustee is independent and Etkin “does not have voting, dispositive, or pecuniary interest” in the securities held by the trust (estate-planning gift).
- No indication of a 10b5-1 plan or tax-withholding event in this filing.
Context Gifts of shares (code G) are common for estate planning and tax/wealth-transfer purposes and do not necessarily signal the insider’s view of the company’s prospects. Because the trust is irrevocable and the trustee is independent, Etkin relinquished voting, dispositive and pecuniary control over these shares per the filing.
Insider Transaction Report
- Gift
Common Stock
[F1]2026-05-14−400,000→ 833,949 total
Footnotes (1)
- [F1]The reporting person transferred 400,000 shares for estate planning purposes to the Bard on Haven Trust, an irrevocable trust, for the benefit of his spouse and children as a bona fide gift for no consideration. The trustee of the trust is independent of the reporting person, and the reporting person does not have voting, dispositive, or pecuniary interest over any of the securities held by the trust.